The IDM has curated a go-to range of reliable information to guide and assist staff and students during this time of crisis. We are continuously updating the various COVID-19 resources listed on our webpage below.
In public health, an important goal of vaccination and immunisation is to reach population or herd immunity. This is why the term comes up often in relation to the COVID-19 pandemic. And it helps to be clear about what it means.
Results published recently in The Lancet Microbe detail analysis of 10 years’ health data, showing a relationship between HIV infection and acquisition of rifampicin resistance by tuberculosis (TB). Rifampicin is an important first‑line anti‑TB medication.
With the fight against COVID-19 beset with concerns around the efficacy of vaccines in the face of a mutating virus, University of Cape Town virologists have shown that the body’s T cells maintain 85% of their capacity to detect variants, continuing to mount a substantial defence to prevent severe illness, hospitalisation and death.
Growing up in Yaoundé, Cameroon, Professor Ambroise Wonkam pursued an atypical career path: medical research. Having decided early on in his education journey that he would follow an academic career, he thought one of the best ways to do this was through training in basic science. For him this meant exploring cell biology, which would end up being his gateway into genetics. An award-winning and world-renowned geneticist recognised for his work in sickle cell disease (SCD), he recently completed a three-year term as the Deputy Dean for Research (DDR) at the University of Cape Town’s (UCT) Faculty of Health Sciences (FHS). Professor Wonkam is one of two recipients of the 2020 Alan Pifer Award.